Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: A qualitative study of patient preferences

Cancer

Volumn 118, Issue 24, 2012, Pages 6270-6277

  Hurley, Karen ^a,b   Rubin, Lisa R ^c   Werner Lin, Allison ^d   Sagi, Michal ^e   Kemel, Yelena ^a   Stern, Rikki ^a   Phillips, Aliza ^c   Cholst, Ina ^f   Kauff, Noah ^a   Offit, Kenneth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PRIVATE PRACTICE   (United States)

^c NEW SCHOOL FOR SOCIAL RESEARCH   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

BRCA1 gene; BRCA2 gene; genetic counseling; health communication; hereditary; neoplastic syndromes; preimplantation diagnosis

Indexed keywords

ADULT; AGE; ARTICLE; ATTITUDE; BREAST CANCER; CANCER RISK; FEMALE; GENE MUTATION; GENETIC COUNSELING; HETEROZYGOTE; HUMAN; INTERVIEW; MALE; OVARY CANCER; PREIMPLANTATION GENETIC DIAGNOSIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REPRODUCTION; RISK MANAGEMENT; TUMOR SUPPRESSOR GENE;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PATIENT PREFERENCE; PREIMPLANTATION DIAGNOSIS; PROGNOSIS; QUALITATIVE RESEARCH; QUESTIONNAIRES; RISK MANAGEMENT; YOUNG ADULT;

EID: 84870668283     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27695     Document Type: Article

References (33)

1. Claes E, Evers-Kiebooms G, Boogaerts A, Cedruyenaere M, Denayer L, Legius E,. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation. Genet Test. 2004; 8: 13-21.
2. Pasacreta JV,. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest. 2003; 21: 588-623.
3. Meiser B, Gaff C, Julian-Reynier C, et al. International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis. 2006-2007; 27: 109-125.
4. Menon U, Harper J, Sharma A, et al. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod. 2007; 22: 1573-1577.
5. Quinn G, Vadaparampil S, Wilson C, et al. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril. 2009; 91: 2361-2368.
6. Quinn GP, Vadaparampil ST, Tollin S, et al. BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none. Fertil Steril. 2010; 94: 2473-2475.
7. Berliner JL, Fay AM,; Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest Group. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2007; 16: 241-260.
8. Offit K, Kohut K, Clagett B, et al. Cancer genetic testing and assisted reproduction. J Clin Oncol. 2006; 24: 4775-4782.
9. Offit K, Sagi M, Hurley K,. Preimplantation genetic diagnosis for cancer syndromes: a new challenge for preventive medicine. JAMA. 2006; 296: 2727-2730.
10. Fortuny D, Balmana J, Grana B, et al. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Hum Reprod. 2009; 24: 1000-1006.
11. Julian-Reynier C, Chabal F, Frebourg T, et al. Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer. J Clin Oncol. 2009; 27: 4475-4480.
12. Braun V, Clarke V,. Using thematic analysis in psychology. Qual Res Psychol. 2006; 3: 77-101.
13. Wang CW, Hui EC,. Ethical, legal and social implications of prenatal and preimplantation genetic testing for cancer susceptibility. Reprod Biomed Online. 2009; 19 (suppl 2): 23-33.
14. Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C,. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients. Ann Surg Oncol. 2009; 16: 1973-1981.
15. Ardern-Jones A, Kenen R, Eeles R,. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care (Engl). 2005; 14: 272-281.
16. Markman M,. Information overload in oncology practice and its potential negative impact on delivery of optimal patient care. Curr Oncol Rep. 2011; 13: 249-251.
17. Skalla KA, Bakitas M, Furstenberg CT, Ahles T, Henderson JV,. Patients' need for information about cancer therapy. Oncol Nursing Forum. 2004; 31: 313-319.
18. Cramer P,. Defense mechanisms in psychology today. Further processes for adaptation. Am Psycholt. 2000; 55: 637-646.
19. Hamilton JG, Lobel M, Moyer A,. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol. 2009; 28: 510-518.
20. Beran TM, Stanton AL, Kwan L, et al. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med. 2008; 36: 107-116.
21. Suls J, Fletcher B,. The relative efficacy of avoidant and nonavoidant coping strategies: a meta-analysis. Health Psychol. 1985; 4: 249-288.
22. Lepore S, Baum A, Andersen B,. A social-cognitive processing model of emotional adjustment to cancer. In:, Baum A, Andersen B, eds. Psychosocial Interventions for Cancer. Washington, DC: American Psychological Association; 2001: 99-116.
23. Ellington L, Kelly KM, Reblin M, Latimer S, Roter D,. Communication in genetic counseling: cognitive and emotional processing. Health Commun. 2011; 26: 667-675.
24. Roter DL, Frankel RM, Hall JA, Sluyter D,. The expression of emotion through nonverbal behavior in medical visits. Mechanisms and outcomes. J Gen Intern Med. 2006; 21 (suppl 1): S28-S34.
25. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN,. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005; 42: 749-755.
26. Carroll JC, Wilson BJ, Allanson J, et al. GenetiKit: a randomized controlled trial to enhance delivery of genetic services by family physicians. Fam Pract. 2011; 28: 615-623.
27. Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K,; American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010; 28: 893-901.
28. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol. 1996; 14: 1730-1736; discussion 1737-1740.
29. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003; 21: 2397-2406.
30. The American Society of Human Genetics. Statement of the American Society of Human Genetics on Genetic Testing for Breast and Ovarian Cancer Predisposition. http://www.ashg.org/pdf/policy/ASHG-PS-November1994.pdf. Accessed August 3, 2011.
31. American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins-Gyneocology; ACOG Committee on Genetics; Society of Gynecologic Oncologists. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009; 113: 957-966.
32. Graves K, Gatammah R, Peshkin B, et al. BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Fam Cancer. 2011; 10: 213-223.
33. Quinn GP, Vadaparampil ST, Miree CA, et al. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer. Hum Reprod. 2010; 25: 2543-2550.